Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer
Open Access
- 14 September 2024
- Vol. 29 (18) , 4375
Abstract
In this study, novel ergosterol peroxide (EP) derivatives were synthesized and evaluated to assess their antiproliferative activity against four human cancer cell lines (A549, HepG2, MCF-7, and MDA-MB-231). Compound 3g exhibited the most potent antiproliferative activity, with an IC50 value of 3.20 µM against MDA-MB-231. This value was 5.4-fold higher than that of the parental EP. Bioassay optimization further identified 3g as a novel glutaminase 1 (GLS1) inhibitor (IC50 = 3.77 µM). In MDA-MB-231 cells, 3g reduced the cellular glutamate levels by blocking the glutamine hydrolysis pathway, which triggered reactive oxygen species production and induced caspase-dependent apoptosis. Molecular docking indicated that 3g interacts with the reaction site of the variable binding pocket by forming multiple interactions with GLS1. In a mouse model of breast cancer, 3g showed remarkable therapeutic effects at a dose of 50 mg/kg, with no apparent toxicity. Based on these results, 3g could be further evaluated as a novel GLS1 inhibitor for triple-negative breast cancer (TNBC) therapy.Keywords
Funding Information
- Heilongjiang Provincial Natural Science Foundation of China (LH2022H113)
This publication has 45 references indexed in Scilit:
- Glutamine metabolism in tumor metastasis: Genes, mechanisms and the therapeutic targetsHeliyon, 2023
- Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategiesBiomedicine & Pharmacotherapy, 2023
- Ergosterol peroxide exhibits antiviral and immunomodulatory abilities against porcine deltacoronavirus (PDCoV) via suppression of NF-κB and p38/MAPK signaling pathways in vitroInternational Immunopharmacology, 2021
- Discovery and optimization of withangulatin A derivatives as novel glutaminase 1 inhibitors for the treatment of triple-negative breast cancerEuropean Journal of Medicinal Chemistry, 2021
- Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathwayEBioMedicine, 2019
- Synthesis of 5α,8α‐Ergosterol Peroxide 3‐Carbamate Derivatives and a Fluorescent Mitochondria‐Targeting Conjugate for Enhanced Anticancer ActivitiesChemMedChem, 2017
- Supporting Aspartate Biosynthesis Is an Essential Function of Respiration in Proliferating CellsCell, 2015
- Glutaminase regulation in cancer cells: a druggable chain of eventsDrug Discovery Today, 2014
- In Vivo HIF-Mediated Reductive Carboxylation Is Regulated by Citrate Levels and Sensitizes VHL-Deficient Cells to Glutamine DeprivationCell Metabolism, 2013
- The Metabolic Profile of Tumors Depends on Both the Responsible Genetic Lesion and Tissue TypeCell Metabolism, 2012